Results 6,561-6,580 of 11,299 for speaker:Colm Burke

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 503. To ask the Minister for Health his views on whether the European Union Pharmaceutical Strategy could place at risk certain intellectual property rights, including those for orphan and paediatric medicines; if such a move could damage jobs, competitiveness and the development of new medicines; and if he will make a statement on the matter. [38285/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 505. To ask the Minister for Health his views on whether there is a role for Ireland, along with other economically advanced, similar-sized countries in supporting the protection of innovation in the European Union Pharmaceutical Strategy in order that Ireland remains competitive for new investments and raise standards of care; and if he will make a statement on the matter. [38287/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 567. To ask the Minister for Health if he will outline the Government’s position on the European Union Pharmaceutical Strategy as the European Commission finalises its proposal for December 2022; and if he will make a statement on the matter. [38788/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 568. To ask the Minister for Health the last time the European Union Pharmaceutical Strategy was discussed at an EPSCO Meeting; if Ireland contributed to that discussion; and if he will make a statement on the matter. [38789/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 569. To ask the Minister for Health if he has engaged with the Department of An Taoiseach in relation to formulating a Government position on the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38790/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 570. To ask the Minister for Health if he has engaged with the Department of Enterprise, Trade and Employment in relation to formulating a position on the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38791/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 571. To ask the Minister for Health if he has engaged with the Department of Further and Higher Education, Research, Innovation and Science in relation to formulating a Government position on the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38792/22]

Written Answers — Department of Health: Covid-19 Pandemic (13 Jul 2022)

Colm Burke: 478. To ask the Minister for Health if he will outline in detail the plans that his Department has to implement guidelines and structures to support general practitioners in assisting patients with long-Covid to ensure that they receive appropriate care; and if he will make a statement on the matter. [38259/22]

Written Answers — Department of Health: Covid-19 Pandemic (13 Jul 2022)

Colm Burke: 479. To ask the Minister for Health if he will outline in detail the way that his Department plans to ensure the Model of Care plan published in September 2021 is fully implemented in all chosen sites; if consideration will be given to updating the plan to reflect the emerging knowledge of the neurological nature of the condition; and if he will make a statement on the matter. [38260/22]

Written Answers — Department of Health: Intellectual Property (13 Jul 2022)

Colm Burke: 502. To ask the Minister for Health his views on whether medicines pricing and intellectual property rights are unrelated, with pricing determined by national governments through industry negotiations and intellectual property rights set through international trade agreements as incentives for innovation; and if he will make a statement on the matter. [38284/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 504. To ask the Minister for Health his views on whether a proposal by an organisation (details supplied) on equity-based tiered pricing would help to broaden access to new medicines for all Europe’s citizens; and if he will make a statement on the matter. [38286/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 506. To ask the Minister for Health if he intends to increase his Department’s representation in Brussels to ensure Ireland’s position is adequately represented in European Council negotiations; and if he will make a statement on the matter. [38288/22]

Ceisteanna Eile - Other Questions: Social Welfare Benefits (14 Jul 2022)

Colm Burke: 83. To ask the Minister for Employment Affairs and Social Protection when the extension of parent's benefit from five to seven weeks will take effect; the number of parents who have availed of parent's benefit to date; and if she will make a statement on the matter. [34987/22]

Ceisteanna Eile - Other Questions: Social Welfare Benefits (14 Jul 2022)

Colm Burke: This question may have been drafted before the announcement. When will the extension of parent's benefit from five to seven weeks take effect? How many parents have availed of parent's benefit to date? Will the Minister make a statement on the matter?

Ceisteanna Eile - Other Questions: Social Welfare Benefits (14 Jul 2022)

Colm Burke: I thank the Minister. I am aware that the extension has only come into place since 1 July. I presume there is budgetary planning in respect of this. Does the Department have any idea of the numbers it expects to benefit from this scheme between now and 31 December? With regard to ongoing planning, what is proposed to adequately plan for 2023 and 2024 to make sure there is adequate...

Ceisteanna Eile - Other Questions: Social Welfare Benefits (14 Jul 2022)

Colm Burke: The Minister will be aware that it is now a very challenging time for young families around the pressures of work and perhaps people do not take the time immediately after their child is born. Will the Department be looking at the issue of caring and childcare in the budget in the context of forward planning? It is an extremely important area. I very much welcome the extension in the...

Joint Oireachtas Committee on Health: Rare Diseases: Discussion (Resumed) (22 Jun 2022)

Colm Burke: I am asking Mr. Woods if there is not a problem if someone has not been specifically designated to be in charge of the review of this national rare diseases plan. Is this then causing frustration within the HSE?

Joint Oireachtas Committee on Health: Rare Diseases: Discussion (Resumed) (22 Jun 2022)

Colm Burke: It might be helpful for the committee if we could get a breakdown of the number over the past five years – Mr. Woods referred to the approximately 29 new orphan drugs approved in 2021 – of new drugs that were brought into the equation in respect of reimbursement and the cost over that time. I understand there were negotiations with the pharmaceutical industry on reducing the...

Public Accounts Committee: 2020 Report of the Comptroller and Auditor General and Appropriation Accounts
An Bord Pleanála - Financial Statements 2020
Vote 34 - Housing, Local Government and Heritage (14 Jul 2022)

Colm Burke: I thank Mr. Walsh for the presentation. I wish to deal with the issue of judicial review. Mr. Walsh said that in 2020 there were 83 new cases and in 2021 there were 95. In respect of the 83 cases in 2020, how many of those have been dealt with or are they still in the court system?

Public Accounts Committee: 2020 Report of the Comptroller and Auditor General and Appropriation Accounts
An Bord Pleanála - Financial Statements 2020
Vote 34 - Housing, Local Government and Heritage (14 Jul 2022)

Colm Burke: How many cases were decided by the High Court in 2020?